Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 3/2017

01-09-2017 | Correspondence

Modified Hyper-CVAD Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation Successfully Treated Synchronous T-Cell Prolymphocytic Leukemia and Gastric Cancer in a 68-Year-Old Female

Authors: Guangquan Zhou, Bai He, Tongbing Chen, Jiannong Cen, Yang Cao, Weiying Gu

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
3.
Dearden CE, Khot A, Else M, Hamblin M, Grand E, Roy A et al (2011) Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. Blood 118(22):5799–5802. doi:10.​1182/​blood-2011-08-372854 CrossRefPubMed
4.
Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J et al (2010) Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. Br J Haematol 149(6):907–910. doi:10.​1111/​j.​1365-2141.​2010.​08134.​x CrossRefPubMed
Metadata
Title
Modified Hyper-CVAD Regimen Followed by Autologous Peripheral Blood Stem Cell Transplantation Successfully Treated Synchronous T-Cell Prolymphocytic Leukemia and Gastric Cancer in a 68-Year-Old Female
Authors
Guangquan Zhou
Bai He
Tongbing Chen
Jiannong Cen
Yang Cao
Weiying Gu
Publication date
01-09-2017
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2017
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0752-1

Other articles of this Issue 3/2017

Indian Journal of Hematology and Blood Transfusion 3/2017 Go to the issue

Original Article

Oleuropein Ameliorates Cisplatin-induced Hematological Damages Via Restraining Oxidative Stress and DNA Injury

Original Article

Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response

Correspondence

Skin GVHD Mimicking Betadine Rash in a Post Allogeneic Transplant Patient

Original Article

Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia

Correspondence

Transfusion Dependent Beta-Thalassemia Developing Avascular Necrosis of Femoral Head: A Rare Case

Correspondence

Long-Term Maintenance of Hematological and Cytogenetic Remission in 5q- Syndrome After Short-Term Administration of Lenalidomide
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits